Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19.: H164-318/2021E-PDF
"This guidance applies to sponsors of new COVID-19 drug submissions as well as sponsors seeking a Notice of Compliance (NOC) for COVID-19 drugs that received temporary authorization under the Interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19 (ISAD IO). It also applies to new COVID-19 drug establishment licences under the Food and Drug Regulations. This document will help manufacturers prepare a submission for a Notice of Compliance for a COVID-19 drug under the Regulations. It also outlines the process for meeting the post-market regulatory requirements"--page 1.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.898414&sl=0
| Department/Agency | Canada. Health Canada, issuing body. |
|---|---|
| Title | Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Lignes directrices sur les modifications apportées au Règlement sur les aliments et drogues pour les médicaments contre la COVID-19. Includes bibliographical references (pages 30-31). |
| Publishing information | [Ottawa] : Health Canada = Santé Canada, 2021. ©2021 |
| Description | 1 online resource (iv, 32 pages) |
| ISBN | 9780660383286 |
| Catalogue number |
|
| Departmental catalogue number | 210010 |
| Subject terms | COVID-19 Pandemic, 2020-2023 -- Health aspects -- Canada. Pharmaceutical policy -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: